Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Greillier

Showing results (11-20 of 153) with videos related to

Pageof 16
Sort By:
Therapeutic Advances in Medical Oncology|May 31, 2016
Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomesPascale Tomasini, Fabrice Barlesi, Celine Mascaux, et al.
Lung Cancer (Amsterdam, Netherlands)|September 11, 2010
Surgical resection of liver non-small cell lung cancer metastasis: a dual weapon?Ecaterina Ileana, Laurent Greillier, Vincent Moutardier, et al.
Expert Review of Anticancer Therapy|March 13, 2013
The place of pemetrexed in the management of non-small-cell lung cancer patientsPascale Tomasini, Laurent Greillier, Nataliya Khobta, et al.
Therapeutic Advances in Medical Oncology|March 17, 2012
Ipilimumab: its potential in non-small cell lung cancerPascale Tomasini, Nataliya Khobta, Laurent Greillier, et al.
Current Oncology Reports|August 18, 2020
Immune Oncology Biomarkers in Lung Cancer: an OverviewCamille Travert, Fabrice Barlesi, Laurent Greillier, et al.
Interactive Cardiovascular and Thoracic Surgery|December 18, 2008
Redo medical thoracoscopy is feasible in patients with pleural diseases - a seriesDavid Breen, Anne Fraticelli, Laurent Greillier, et al.
Expert Review of Anticancer Therapy|December 5, 2018
Therapeutic potential of trametinib to inhibit the mutagenesis by inactivating the protein kinase pathway in non-small cell lung cancerArnaud Jeanson, Arnaud Boyer, Laurent Greillier, et al.
Targeted Oncology|July 30, 2020
Antibody-Drug Conjugates in Thoracic Malignancies: Clinical Trials Reveal Both Promise and ChallengesSandrine Payan, Marc Montana, Christophe Curti, et al.
Therapeutic Advances in Respiratory Disease|February 22, 2019
Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastasesPascale Tomasini, Julie Egea, Maxime Souquet-Bressand, et al.
Molecular Diagnosis & Therapy|November 28, 2008
Biomarkers for malignant pleural mesothelioma: current statusLaurent Greillier, Paul Baas, John J Welch, et al.
Pageof 16

Showing results (11-20 of 153) with videos related to

Sort By:
Pageof 16
Therapeutic Advances in Medical Oncology|May 31, 2016
Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomesPascale Tomasini, Fabrice Barlesi, Celine Mascaux, et al.
Lung Cancer (Amsterdam, Netherlands)|September 11, 2010
Surgical resection of liver non-small cell lung cancer metastasis: a dual weapon?Ecaterina Ileana, Laurent Greillier, Vincent Moutardier, et al.
Expert Review of Anticancer Therapy|March 13, 2013
The place of pemetrexed in the management of non-small-cell lung cancer patientsPascale Tomasini, Laurent Greillier, Nataliya Khobta, et al.
Therapeutic Advances in Medical Oncology|March 17, 2012
Ipilimumab: its potential in non-small cell lung cancerPascale Tomasini, Nataliya Khobta, Laurent Greillier, et al.
Current Oncology Reports|August 18, 2020
Immune Oncology Biomarkers in Lung Cancer: an OverviewCamille Travert, Fabrice Barlesi, Laurent Greillier, et al.
Interactive Cardiovascular and Thoracic Surgery|December 18, 2008
Redo medical thoracoscopy is feasible in patients with pleural diseases - a seriesDavid Breen, Anne Fraticelli, Laurent Greillier, et al.
Expert Review of Anticancer Therapy|December 5, 2018
Therapeutic potential of trametinib to inhibit the mutagenesis by inactivating the protein kinase pathway in non-small cell lung cancerArnaud Jeanson, Arnaud Boyer, Laurent Greillier, et al.
Targeted Oncology|July 30, 2020
Antibody-Drug Conjugates in Thoracic Malignancies: Clinical Trials Reveal Both Promise and ChallengesSandrine Payan, Marc Montana, Christophe Curti, et al.
Therapeutic Advances in Respiratory Disease|February 22, 2019
Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastasesPascale Tomasini, Julie Egea, Maxime Souquet-Bressand, et al.
Molecular Diagnosis & Therapy|November 28, 2008
Biomarkers for malignant pleural mesothelioma: current statusLaurent Greillier, Paul Baas, John J Welch, et al.
Pageof 16